Protagonist Therapeutics (PTGX) Analyst & Key Data

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts21

Ratings

Updated Sep 12, 2026

Overall Rating

B

DCF Score1.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score5.0 / 5

ROE Score4.0 / 5

Valuation

Current Stock Price

$148.18

Median Target-7.00%

$137.81

Potential downside vs current price

DCF Value-106.22%

-$9.22

Potential downside vs current price

Current Stock Price

$148.18

Median Target-7.00%

$137.81

Potential downside vs current price

DCF Value-106.22%

-$9.22

Potential downside vs current price

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts21

Ratings

Updated Sep 12, 2026

Overall Rating

B

DCF Score1.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score5.0 / 5

ROE Score4.0 / 5

Valuation

Current Stock Price

$148.18

Median Target-7.00%

$137.81

Potential downside vs current price

DCF Value-106.22%

-$9.22

Potential downside vs current price

Current Stock Price

$148.18

Median Target-7.00%

$137.81

Potential downside vs current price

DCF Value-106.22%

-$9.22

Potential downside vs current price

Protagonist Therapeutics, Inc.